<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05081544</url>
  </required_header>
  <id_info>
    <org_study_id>2021PBMD01</org_study_id>
    <secondary_id>2021-A00733-38</secondary_id>
    <nct_id>NCT05081544</nct_id>
  </id_info>
  <brief_title>Impact of Multi-tasking Situations on the Dismounted Soldier's Cognitive Load</brief_title>
  <acronym>SiMuCCoDé</acronym>
  <official_title>Impact of Multi-tasking Situations on the Dismounted Soldier's Cognitive Load</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Direction Centrale du Service de Santé des Armées</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Direction Centrale du Service de Santé des Armées</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The increased complexity of the dismounted combatant's equipment can result in a strain on&#xD;
      the various senses (e.g., visual, auditory) that can exceed an individual's limited&#xD;
      information processing abilities. The combatant may thus be cognitively overloaded in&#xD;
      multi-tasking operational situations.&#xD;
&#xD;
      There has been a great deal of research conducted on cognitive load. A battery of&#xD;
      multitasking tests has been developed in the field of aeronautics, but, to our knowledge, no&#xD;
      measurement of cognitive load specifically dedicated to combatants has been conducted yet.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive load level</measure>
    <time_frame>At enrollment (Day 1)</time_frame>
    <description>Cognitive load level will be measured using NASA-TLX questionnaire. NASA-TLX questionnaire comprises 6 dimensions (mental demands, physical demands, time demands, performance, effort and frustration). Each dimension has a score ranging from 0 (low cognitive load) to 100 (high cognitive load), except for the &quot;performance&quot; dimension, whose score ranges from 0 (good performance) to 100 (low performance).</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cognitive Load</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be composed of healthy volunteers from several French infantry&#xD;
        regiments (group leaders).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  be a group leader in an infantry regiment,&#xD;
&#xD;
          -  be over 18 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  be a woman,&#xD;
&#xD;
          -  have a heart condition,&#xD;
&#xD;
          -  have a visual disease not corrected by glasses or contact lenses,&#xD;
&#xD;
          -  have a hearing score ≥ 2 on the SIGYCOP,&#xD;
&#xD;
          -  have a psychiatric disorder, a progressive neurological or organic disease requiring&#xD;
             drug treatment,&#xD;
&#xD;
          -  take psychotropic drugs,&#xD;
&#xD;
          -  take more than 28 units of alcohol per week.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julie ALBENTOSA, PhD</last_name>
    <phone>178651217</phone>
    <phone_ext>+33</phone_ext>
    <email>julie.albentosa@intradef.gouv.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut de Recherche Biomédicale des Armées</name>
      <address>
        <city>Brétigny-sur-Orge</city>
        <zip>91223</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Julie ALBENTOSA, PhD</last_name>
      <phone>178651217</phone>
      <phone_ext>+33</phone_ext>
      <email>julie.albentosa@intradef.gouv.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 7, 2021</study_first_submitted>
  <study_first_submitted_qc>October 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cognitive load</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

